Ads
related to: breast cancer molecular targeted therapy- Treatment Information
Read About This Treatment Option.
Learn How This Option May Help.
- Early Breast Cancer
Find Condition Information.
Understand eBC.
- Patient FAQ Answers
View Frequently Asked Questions.
Get Answers To Common Questions.
- Patient Support Program
Access Personalized Support.
View Financial Support Options.
- Managing Day To Day
Info For Day To Day Support.
Find Support Organizations.
- Clinical Data
See The Data For This Option.
eBC Clinical Trial Information.
- Treatment Information
Search results
Results From The WOW.Com Content Network
Targeted Therapy Database (TTD) from the Melanoma Molecular Map Project ; Targeted therapy Fact sheet from the U.S. National Cancer Institute; Molecular Oncology: Receptor-Based Therapy Special issue of Journal of Clinical Oncology (April 10, 2005) dedicated to targeted therapies in cancer treatment
The safety and efficacy of trastuzumab-containing combination therapies (with chemotherapy, hormone blockers, or lapatinib) for the treatment of metastatic breast cancer. [clarification needed] The overall hazard ratios (HR) for overall survival and progression free survival were 0.82 and 0.61, respectively.
Trastuzumab deruxtecan is indicated for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting and for adults with locally advanced or metastatic HER2-positive gastric or gastroesophageal ...
Treatment types can be classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies). Local therapy is most efficacious in early stage breast cancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific phenotypes.
This is an accepted version of this page This is the latest accepted revision, reviewed on 2 January 2025. Cancer that originates in mammary glands Medical condition Breast cancer An illustration of breast cancer Specialty Surgical Oncology Symptoms A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on ...
Therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer), are now called hormonal therapies. Other inhibitions of growth-signals, such as those associated with receptor tyrosine kinases, are targeted therapy.
Ads
related to: breast cancer molecular targeted therapy